{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "ETV Procedures Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Table 4",
        "sectionTitle": "ETV Procedures",
        "description": "Reference to Table 4 for procedures at an Early Termination Visit (ETV)"
      },
      {
        "id": "ref_2",
        "name": "Unscheduled Visit Procedures Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Table 4",
        "sectionTitle": "V997 Unscheduled Visit",
        "description": "Reference to Table 4 V997 for procedures at an unscheduled visit"
      },
      {
        "id": "ref_3",
        "name": "AESI Data Collection Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.3.6",
        "sectionTitle": "Adverse Events of Special Interest",
        "description": "Reference to Section 8.3.6 for additional data collection for AESIs"
      },
      {
        "id": "ref_4",
        "name": "Physical Examination Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.2.2",
        "sectionTitle": "Physical Examination",
        "description": "Reference to Section 8.2.2 for complete physical examination details"
      },
      {
        "id": "ref_5",
        "name": "Symptom-Directed Physical Examination Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "8.2.2",
        "sectionTitle": "Physical Examination",
        "description": "Reference to Section 8.2.2 for symptom-directed physical examination including TB assessment"
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "V1 and V9 procedures may be conducted over more than 1 day as long as all activities are completed within the allowable visit tolerance and all scheduled activities are completed prior to dosing.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities Table 1",
        "pageNumber": 1
      },
      {
        "id": "annot_2",
        "text": "Site staff explains, participant reports remission/normal stool frequency",
        "annotationType": "Comment",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Informed consent",
        "pageNumber": 1
      },
      {
        "id": "annot_3",
        "text": "The purpose of UC remission question should be explained before the participant answers the question. Errors in the response cannot be corrected after the participant saves and confirms the response.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - UC Remission Question",
        "pageNumber": 1
      },
      {
        "id": "annot_4",
        "text": "Includes relevant surgical history.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Preexisting conditions and medical history",
        "pageNumber": 1
      },
      {
        "id": "annot_5",
        "text": "Indication and history of interest.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Prespecified medical history",
        "pageNumber": 1
      },
      {
        "id": "annot_6",
        "text": "Includes all UC-specific therapies since date of diagnosis.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Prior treatments for indication",
        "pageNumber": 1
      },
      {
        "id": "annot_7",
        "text": "For AESIs, additional data are collected (Section 8.3.6).",
        "annotationType": "Reference",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Adverse events",
        "pageNumber": 1
      },
      {
        "id": "annot_8",
        "text": "Participant should remove shoes.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Height",
        "pageNumber": 2
      },
      {
        "id": "annot_9",
        "text": "Blood pressure, body temperature, and pulse rate. Vital signs should be measured after participant has been sitting at least 5 minutes.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Vital signs",
        "pageNumber": 2
      },
      {
        "id": "annot_10",
        "text": "The complete physical exam excludes pelvic, rectal, and breast exams, unless clinically indicated, and includes assessment for signs and symptoms of tuberculosis (TB), including peripheral lymph nodes.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Physical examination",
        "pageNumber": 2
      },
      {
        "id": "annot_11",
        "text": "Locally performed.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - 12-lead electrocardiogram (ECG)",
        "pageNumber": 2
      },
      {
        "id": "annot_12",
        "text": "Interpreted and reported by radiologist or pulmonologist. Not done at screening if done within 3 months before screening and if qualifying radiographs or equivalent imaging study and/or formal report are available for investigator's review. Lateral view may also be taken. Locally performed.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Chest x-ray",
        "pageNumber": 3
      },
      {
        "id": "annot_13",
        "text": "Check compliance for Stool Frequency, Rectal Bleeding, Nocturnal Stools, Bristol Stool Scale, Urgency NRS, Abdominal Pain NRS, Fatigue NRS, and Patient Global Rating of Severity (PGR-S).",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Diary compliance check",
        "pageNumber": 3
      },
      {
        "id": "annot_14",
        "text": "Adapted for the assessment of ideation and behavior categories only.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - C-SSRS Screening/Baseline",
        "pageNumber": 4
      },
      {
        "id": "annot_15",
        "text": "Required if triggered by the Self-Harm Supplement Form per instructions.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Self-Harm Follow-Up Form",
        "pageNumber": 4
      },
      {
        "id": "annot_16",
        "text": "Fasting samples are preferred, but if participant is non fasting at time of collection, this is not a protocol deviation.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Lipid panel",
        "pageNumber": 4
      },
      {
        "id": "annot_17",
        "text": "Perform only for women of childbearing potential and women with a history of tubal ligation.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Serum pregnancy",
        "pageNumber": 4
      },
      {
        "id": "annot_18",
        "text": "Perform only for women of childbearing potential and women with a history of tubal ligation. At dosing visits which have pregnancy testing, the pregnancy test result must be confirmed to be negative prior to dosing. Pregnancy testing may be performed more frequently than designated on the SoA, if local laws or regulations require more frequent testing.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Urine pregnancy (local)",
        "pageNumber": 5
      },
      {
        "id": "annot_19",
        "text": "Optional, perform only for women not of childbearing potential to confirm postmenopausal status.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Follicle-stimulating hormone (FSH)",
        "pageNumber": 5
      },
      {
        "id": "annot_20",
        "text": "Patients who had a tuberculin skin test (TST) will return from 48 to 72 hours after placement to have the test result read. Samples may be sent to central or local laboratory based on the type of test. A local laboratory must be qualified by local regulations.",
        "annotationType": "Clarification",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Tuberculosis (TB) test",
        "pageNumber": 5
      },
      {
        "id": "annot_21",
        "text": "HCV RNA will be measured to confirm positive hepatitis C virus antibody.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Hepatitis C virus (HCV) screening tests",
        "pageNumber": 5
      },
      {
        "id": "annot_22",
        "text": "Includes testing for HBsAg and anti-HBc.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Schedule of Activities - Hepatitis B virus (HBV) screening tests",
        "pageNumber": 5
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "b",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "description": "Protocol J1P-MC-KFAH(b) - Schedule of Activities for Screening and Induction Treatment Periods",
        "amendmentNumber": "Amendment b"
      }
    ],
    "summary": {
      "referenceCount": 5,
      "annotationCount": 22,
      "versionCount": 1
    }
  }
}